Synopsis

“Chromalloy Gas Turbine LLC: Aerospace and Defense – Company Profile & SWOT Report” contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, recent developments, key employees as well as company locations and subsidiaries.

Summary

This report is a crucial resource for industry executives and anyone looking to access key information about “Chromalloy Gas Turbine LLC”

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Strategic Defence Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Browse Full Report @http://www.jsbmarketresearch.com/aerospace/r-chromalloy-gas-turbine-llc-aerospace-and-defense-company-profile-and-swot-report-129311

Scope

Examines and identifies key information and issues about “Chromalloy Gas Turbine LLC” for business intelligence requirements.

Studies and presents the companys strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.

The profile also contains information on business operations, company history, major products and services, key employees, and locations and subsidiaries.

Reasons To Buy

Quickly enhance your understanding of “Chromalloy Gas Turbine LLC”

Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

Increase business/sales activities by understanding your competitors businesses better

Recognize potential partnerships and suppliers.

Key Highlights

Chromalloy Gas Turbine LLC (Chromalloy) is a provider of jet engine and turbine engine components and services. The company provides engine part coatings, repairs, castings, manufacturing, overhauls and engine maintenance. It primarily serves commercial airlines, military, industrial gas turbines and marine markets. It provides a full line of repair and maintenance capabilities for turbine engines. In addition, it supports a wide range of military gas turbine engines including F110 series, J85, PT6, CT58, LM2500, AGT 1500, CF6-50 and CF6-80, among others. Furthermore, it provides components to the original equipment manufacturers (OEMs) and repair components for marine and land-based aero derivative and industrial turbine engines used for power generation. The company operates as a subsidiary of Sequa Corporation. Chromalloy is headquartered in Palm Beach Gardens, Florida, the US.

Summary

Tobacco Insights 2014 – September is a new extensive market research covering the global tobacco market. It provides an analysis of changing production and consumption patterns and the recent developments impacting the tobacco market. It provides a regional analysis of cigarette consumption including import and export share by region.

Key Findings

Egypts Eastern Tobacco has just reported a 20.4% increase in revenues, for the year ending the 30th of June 2014, to E6.2 billion and posted profits of E908.4 million – up from E754.4 million a year earlier.

In August 2014 production of cigarettes in Canada decreased by 10.6% over the same period a year earlier, to 1,525.3 million pieces. Compared with July 2014, the figure is 26.2% lower.

Philip Morris International has been fined over US$ 480,000 by the State of Sao Paulo for targeting youth with its Be Marlboro advertisements.

Browse Full Report @http://www.jsbmarketresearch.com/consumer-goods/r-tobacco-insights-2014-september-129303

Synopsis

Tobacco Insights 2014 – September report is a qualitative report providing extensive and highly detailed consumption insight on the Tobacco industry across the globe.

This report is the result of ERCs extensive market research covering Tobacco across globe. The report provides consumption data based upon a unique combination of industry research, fieldwork, market sizing work and our in-house expertise in the Tobacco industry in order to offer data about the trends and dynamics affecting the Tobacco industry.

This report is aimed at companies operating in the Tobacco industry and for new companies considering entry into Tobacco industry.

This report provides data and recent activities of the manufacturers operating in the Tobacco industry in the key markets.

Reasons To Buy

Tobacco companies require a detailed understanding of Tobacco consumption in order to align their sales and marketing efforts with the latest trends in the market. This report clarifies in detail, by region and company, where the growth opportunities are in Tobacco industry to enable effective marketing plan

As consumers product demands evolve, the dynamics between different countries also change favoring some countries and leaving others increasingly out of line with demand patterns. As a result, understanding the shifting market dynamics is key to ensuring maximum sales in the future

The differing growth rates in overall regional product sales drive fundamental shifts in the market. This report provides detailed, authoritative data on these changes for marketers

The report provides the latest data on market dynamics in the Tobacco industry across globe, providing marketers with essential data and insight in order to understand their own position in the market and to identify where to compete in the future

Summary

The Cider Market Insight Germany report contains detailed brand, distribution and packaging data and analysis across the Germany cider market for 2013. Brand and packaging volume data is available whilst value data is also available for distribution data. Text analysis reveals the drivers behind the data.

Key Findings

Cider volumes rise
Flavor mixes increase in volume
Cider being promoted outside traditional regions

Browse Full Report @http://www.jsbmarketresearch.com/food-beverages/r-cider-market-insights-germany-126932

Synopsis

Cider Market Insight reports provide detailed data and textual analysis of the beer category and the report contains four sections plus an Executive Summary, a concise Summaryof the report including Key Findings and drivers.

Section 1: Market Update

Each section contains text explaining the main drivers behind the 2013 data
– Current and Emerging Trends
– Outlook
– Imports and Exports
– Segmentation
– Brand Analysis
– Private Label/Private Label Producers
– New Products and Photo Shots
– Market Structure
– Cider Producers/Importers
– Packaging Trends
– Channel Analysis
– Market Valuation and Pricing
– Distribution Trends
– Cider Pricing Tables
– Cider Data Tables*

Section 2: Brewer Profiles
A brief history of each major player in the country along with discussion of facilities, key events and developments in 2013

*Data is segmented by the following attributes in Beer Market Insight reports;
Brand;
– Alcoholic Strength
– Cider Type
– Brand
– Brand Owner
– Brewed In
– Calorie Rating
– Country of Origin
– Geographic Scope
– Geography
– Local Operator
– Local Segment
– Modus Operandi
– Price Segment
– PL indicator
– Trademark Brand

Distribution;
– Off-premise
– Off-premise sub channel
– On-premise
– On-premise sub channel
– Price Segmentation

Packaging;
– Pack Material
– Pack Type
– Pack Size
Refillable Indicator

Reasons To Buy

The Market Insight Germany report contains detailed data segmented by many attributes which gives you a cohesive picture of the market and this data is combined with insight into the drivers of trends allowing you to identify opportunities and threats within the Germany market. The extensive data shows you the performance of brands and brewers allowing you to compare and track performances. This report identifies how companies can capitalize on current consumer trends and increase volume and profit of their brands by expanding their operations into new areas.

Summary

“Oil and Gas Business Confidence Report Q3 2014” is a new report that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the Oil and Gas industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over July–September 2014. In addition, it provides an overview of the key priorities, threats, and opportunities for the global Oil and Gas industry over July–September 2014.

Key Findings

Overall, 46% of Oil and Gas industry respondents state that they are operating in a stable economic environment, while 30% state that their current economic conditions are favorable

The majority of global Oil and Gas industry respondents anticipate positive growth for both their companies and the industry over July–September 2014

Industry respondents from North America expect the highest growth in sales volume in July–September 2014

Protecting and growing market share and customer retention are the most popular priorities by Oil and Gas industry executives operating across all regions

Browse Full Report @http://www.jsbmarketresearch.com/energy-utilities/r-oil-and-gas-business-confidence-report-129237

Synopsis

This report is the result of an extensive survey drawn from Kable’s exclusive panel of leading global Oil and Gas industry executives. The report analyzes current global economic conditions and their impact on the Oil and Gas industry, and forecasts the company and industry growth prospects over July–September 2014. It provides information about the impact of customer confidence, supplier prices, and staff headcount likely to affect investment decisions over July–September 2014.

In particular, it provides an in-depth analysis of the following:

The growth prospects of companies and the industry as a whole: providing industry executives’ expectations on the growth prospects of their company and the Industry over July–September 2014

Change in customer confidence: analyzing Oil and Gas industry executives’ opinions on changes in customer confidence globally, over July–September 2014

Impact of supplier prices: determining the expected change in supplier prices across various categories and their impact on business confidence, and examines the key factors influencing the change

Change in staff headcount and sales performance: tracking the expected changes in staff headcount and sales among industry executives operating in various regions, over July–September 2014

Investment activities: ascertaining the various investment activities on which industry executives intend to focus on over July–September 2014

Business concerns: examining industry executives’ attitudes towards various business concerns and provides regional analysis

Key priorities: identifying the immediate business priorities of oil and gas industry executives over July–September 2014

Reasons To Buy

The report projects the current and future operating conditions of the Oil and Gas industry, and allows readers to make effective business decisions

The report helps readers to make strategic decisions by understanding the present and future economic, and customer issues including key growth regions

Oil and Gas industry suppliers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the industry’s growth prospects

The report forecasts the change in supplier prices of various products, which are likely to influence the industry’s growth prospects over July–September 2014

The report helps executives recognize the change in customer confidence levels in the global Oil and Gas industry over July–September 2014

Summary

Understanding Consumer Trends and Drivers of Behavior in the US Make-up Market provides an overview of the market, analyzing market data, demographic consumption patterns within the category, and the key consumer trends driving consumption. The report highlights innovative new product development that effectively targets the most pertinent consumer need states, and offers strategic recommendations to capitalize on evolving consumer landscapes.

Key Findings

The primary trend influencing Make-up consumption in the US is Individualism, illustrating that consumers are seeking Make-up that is specifically tailored to their skin type and tone

As Make-up is considered an essential daily wear item for many US consumers, Better Value for Money is an important trend in the market with consumers seeking value both in the lowest price products and in those offering some form of added value

US consumers are seeking indulgence through their Make-up consumption, which is supported by the non-essential nature of the category and the increasingly opulent products that are available

US women look to their Make-up consumption to provide them with escapism from building daily stresses; as increasing numbers of women work alongside running a household and looking after children, many are using their Make-up consumption to take some time out for themselves

Browse Full Report @http://www.jsbmarketresearch.com/Personal-Care/r-consumer-trends-analysis-understanding-consumer-trends-and-drivers-of-behavior-in-the-us-make-up-market-129240

Synopsis

Understanding Consumer Trends and Drivers of Behavior in the US Make-up Market identifies the key demographic groups driving consumption, and what motivates their consumption. The report uses a unique method of quantifying consumer trends to highlight the degree of influence they have on consumption within the category. The report also identifies the most important trends within the market and shows whether beliefs over what influences consumer behavior within the category are accurate.

Get access to:

Key consumer demographic groups driving consumption within the US market. The figures showcase the number of times consumers of specific ages and gender consume Make-up, as well as identifying whether these demographic groups “”over”” consume in the category (i.e. they account for a higher proportion of occasions than the proportion of society they represent overall).

Market value and volumes over 20082018 for US and nine other countries to give a global context.

The degree of influence that the 20 key consumer trends identified by Canadean have on Make-up consumption volumes, with granular analysis on the extent that degree of influences varies between gender and age group.

Insight into the implications behind the data, and analysis of how the needs of will evolve in the short-to-medium term future.

Examples of international and US-specific product innovation targeting key consumer needs.

Reasons To Buy

This report brings together consumer analysis and market data to provide actionable insight into the behavior of US Make-up consumers. This is based on Canadeans unique consumer data, developed from extensive consumption surveys and consumer group tracking, which quantifies the influence of 20 consumption motivations in the Make-up sector. This allows product and marketing strategies to be better aligned with the leading trends in the market.

Summary

The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the UK is poised to undergo a dramatic shift during the forecast period. Disease management of the four largest B-cell NHL indications, which includes Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL), and Mantle Cell Lymphoma (MCL), currently revolves around multiple rounds of Rituxan-based chemotherapy. Although patients can achieve durable remissions to induction therapy, those patients who relapse after primary treatment have poor prognosis and high unmet needs. Several promising pipeline agents are set to have a dramatic impact on treatment of these relapsed/refractory patients over the forecast period: Pharmacyclics’/Janssen’s Imbruvica, which was approved for relapsed/refractory MCL patients in November 2013, Gilead’s Zydelig, which was approved for relapsed/refractory FL patients in July 2014, and Roche’s Gazyva, which will launch in 2015.

Highlights

Key Questions Answered

How will the launch of Imbruvica and Zydelig impact the treatment landscape of relapsed/refractory MCL and FL patients?

How will the launch of Gazyva and the subcutaneous formulation of MabThera help Roche protect their hematology franchise from biosimilar rituximab competition in the 5EU?

The new agents will launch first in one B-cell indication before seeking label expansion into broader NHL patient populations. How will companies expand their hematology candidates beyond their initial approvals?

Pharmacyclics has set a high pricing bar with a high ACOT for Imbruvica. How will this pricing strategy affect pricing of other pipeline agents, and will this be a barrier to entry in cost-conscious EU markets?

The new agents address significant unmet needs in the relapsed/refractory NHL population. What remaining opportunity will remain after their launch?

Key Findings

Imbruvica will gain significant patient share in the relapsed/refractory MCL market before expanding into the r/r FL setting. However, Zydelig’s time-to-market advantage as well as potentially superior clinical profile in FL patients will result in Zydelig maintaining the market lead in these patients.

There is significant opportunity for the new agents Imbruvica and Zydelig, which are delivered orally and would greatly increase patient convenience in addition to providing superior clinical benefit over chemoimmunotherapy regimens.

Physicians in the US and 5EU are eager to eventually transition their patients onto chemo-free combination regimens, and the new oral agents in combination with Rituxan or Gazyva have the potential to address this need in the first line.

The loss of patent protection in 2013 for the gold-standard CD20 antibody MabThera (Rituxan) will have a significant impact on market growth in the 5EU, as biosimilar competition is expected beginning in 2018. By launching the second-generation CD20 antibody Gazyva, as well as a subcutaneous formulation of MabThera that greatly increases patient convenience, Roche will effectively maintain significant NHL patient share over biosimilar competitors in 2018.

Many relapsed/refractory NHL patients seek treatment in clinical trials, due to the low clinical efficacy conferred by available chemoimmunotherapy regimens after failure of first-line treatment. As the pipeline agents gain approval and enter the market, GlobalData anticipates that trial registration will decrease, contributing to overall market growth in the US and 5EU as more patients opt to receive treatment outside of the clinical trial setting.

Scope

Overview of B-cell NHL, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines for DLBCL, FL, MZL and MCL.

Annualized B-cell NHL (including DLBCL. FL. MZL and MCL) therapeutics market revenue, annual cost of therapy and patient share in the first-line and relapsed/refractory setting (as well as consolidation/maintenance for FL patients) forecast from 2013 to 2018.

Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the B-cell NHL therapeutics market

Pipeline analysis: The B-cell NHL pipeline is relatively small, but dominated by high profile novel therapies with the potential to be significant game changers.

Analysis of the current and future market competition in the global B-cell NHL markets, including insightful review of the key industry drivers, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

Develop business strategies by understanding the trends shaping and driving the B-cell NHL therapeutics markets in the US and 5EU.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global NHL therapeutics market in future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Forecast drug sales in the global B-cell NHL therapeutics market from 2013-2018.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies